永新股份：12月9日召开董事会会议

Group 1 - The company Yongxin Co., Ltd. (SZ 002014) held a temporary board meeting on December 9, 2025, to discuss the election of non-independent directors for the ninth board [1] - For the first half of 2025, Yongxin's revenue composition was as follows: 92.98% from other plastic manufacturing, 4.24% from coatings, inks, and similar products, and 2.79% from other businesses [1] - As of the report date, Yongxin's market capitalization was 7.2 billion yuan [1] Group 2 - The news highlights a significant issue in the pharmaceutical industry regarding the abuse of pregabalin, marking the first reported case of addiction in China [1] - The report indicates vulnerabilities in online platforms that allow the purchase of medications without medical records, raising concerns about regulatory oversight [1] - The classification of pregabalin and the need for scientific evaluation regarding its regulation are emphasized [1]